Author

M. Bergmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. Tiefenbacher· 2 shared G. Egger· 2 shared J. Kabiljo· 2 shared L. Tran· 2 shared T. Mair· 2 shared V. S. Atanasova· 2 shared A. Ianevski· 1 shared A. Orlova· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Tiefenbacher

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Aggressive KRAS mutations direct TGF-β response towards partial EMT in patient-derived colorectal cancer tumoroids

T. Mair, P. König, M. Mijovic, L. Tran, P. M. Saldana, C. U. P. Malla, K. Draganic, J. Pfneissl, A. Tiefenbacher, J. Kabiljo, V. S. Atanasova, J. Kalla, L. Wozelka-Oltjan, L. Müllauer, M. Bergmann, , G. Egger

This study investigates how TGF-β affects colorectal cancer tumoroids, finding that aggressive KRAS mutations lead to partial EMT and increased invasiveness.

bioRxiv · Jun 25, 2024 · PreprintCancer Biology

Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma

D. Pölöske, H. Sorger, A. Schönbichler, E. D. de Araujo, H. A. Neubauer, A. Orlova, S. H. Timonen, D. I. Abdallah, A. Ianevski, H. Kuusanmäki, M. Surbek, C. Wagner, T. Suske, M. L. Metzelder, M. Bergmann, , R. Moriggl

This study evaluates small molecule STAT3/5 inhibitors for treating AML and NKCL, showing growth arrest and synergy with existing therapies in vitro and in vivo.

bioRxiv · Oct 12, 2023 · PreprintCancer Biology

Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model

V. S. Atanasova, C. d. J. Cardona, V. Hejret, A. Tiefenbacher, L. Tran, C. Binder, T. Mair, J. Kabiljo, J. Clement, K. Woeran, B. Neudert, M. Hengstschlaeger, M. Mitterhauser, L. Muellauer, B. Tichy, , G. Egger

This paper develops a colorectal cancer organoid model incorporating patient-derived fibroblasts, showing enhanced cellular heterogeneity and morphology compared to mono-cultures.

bioRxiv · Mar 7, 2022Cancer Biology

Long-term in vivo Monitoring of Gliotic Sheathing of Ultrathin Entropic Coated Brain Microprobes with Fiber-based Optical Coherence Tomography

I. Dryg, Y. Xie, M. Bergmann, G. Urban, W. Shain, U. Hofmann

This study uses OCT to monitor long-term tissue response around brain implants, finding that Parylene coatings do not reduce glial encapsulation.

bioRxiv · Feb 26, 2020Bioengineering